These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 36323488)

  • 1. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
    Fragoulis GE; Dey M; Zhao S; Schoones J; Courvoisier D; Galloway J; Hyrich KL; Nikiphorou E
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36323488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
    Fragoulis GE; Nikiphorou E; Dey M; Zhao SS; Courvoisier DS; Arnaud L; Atzeni F; Behrens GM; Bijlsma JW; Böhm P; Constantinou CA; Garcia-Diaz S; Kapetanovic MC; Lauper K; Luís M; Morel J; Nagy G; Polverino E; van Rompay J; Sebastiani M; Strangfeld A; de Thurah A; Galloway J; Hyrich KL
    Ann Rheum Dis; 2023 Jun; 82(6):742-753. PubMed ID: 36328476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.
    van Assen S; Elkayam O; Agmon-Levin N; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JP; Jayne DR; Kallenberg CG; Müller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M
    Autoimmun Rev; 2011 Apr; 10(6):341-52. PubMed ID: 21182987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.
    Rondaan C; Furer V; Heijstek MW; Agmon-Levin N; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; van Assen S; Elkayam O
    RMD Open; 2019; 5(2):e001035. PubMed ID: 31565247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections.
    Clemente D; Cuadros EN; Lovillo MC; Hernández JC; Martín SG; Silveira LF; Cruz MJL; Tagarro A; Rueda RMA; López López A; Aritziturri MS; Calvo C
    Eur J Pediatr; 2024 Feb; 183(2):915-927. PubMed ID: 38047962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
    Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.
    Su J; Long L; Zou K
    Clin Rheumatol; 2018 Dec; 37(12):3201-3214. PubMed ID: 29637482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for losing hepatitis B virus surface antibody in patients with HBV surface antigen negative/surface antibody positive serostatus receiving biologic disease-modifying anti-rheumatic drugs: a nested case-control study.
    Hung MH; Tien YC; Chiu YM
    Adv Rheumatol; 2021 Apr; 61(1):22. PubMed ID: 33832541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
    Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
    Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
    Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
    Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.
    Furer V; Rondaan C; Heijstek M; van Assen S; Bijl M; Agmon-Levin N; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
    RMD Open; 2019; 5(2):e001041. PubMed ID: 31673420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
    van Assen S; Agmon-Levin N; Elkayam O; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JP; Jayne DR; Kallenberg CG; Müller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M
    Ann Rheum Dis; 2011 Mar; 70(3):414-22. PubMed ID: 21131643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
    Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
    Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis.
    Moghoofei M; Mostafaei S; Ashraf-Ganjouei A; Kavosi H; Mahmoudi M
    Microb Pathog; 2018 Jan; 114():436-443. PubMed ID: 29223453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
    Mori S; Fujiyama S
    World J Gastroenterol; 2015 Sep; 21(36):10274-89. PubMed ID: 26420955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases.
    Pyo J; Cho SK; Kim D; Sung YK
    Korean J Intern Med; 2018 Nov; 33(6):1241-1251. PubMed ID: 29277097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021.
    Jansen MHA; Rondaan C; Legger GE; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg L; Berbers GAM; Bruijning P; Egert Y; Normand C; Bijl M; Foster HE; Koné-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
    Ann Rheum Dis; 2023 Jan; 82(1):35-47. PubMed ID: 35725297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.